A Randomized Controlled Trial Comparing the Efficacy of Commercial Weight Management Programs
NCT ID: NCT06972277
Last Updated: 2026-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
459 participants
INTERVENTIONAL
2025-05-14
2026-01-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Food, Activity and Behavior Trial
NCT00640900
The Effects of a Weight Management Program on Body Weight and Quality of Life
NCT02219763
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
NCT03037567
Managing Obesity by Combining Behavioral Weight Loss and Commercial Approaches
NCT00827593
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
NCT03928483
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Commercial weight management program 1
Participants in this group receive behavioral / lifestyle support from an evidence-based commercial weight management program.
Commercial weight management program
Participants will receive evidence-based behavioral / lifestyle support from a commercial weight management program.
Commercial weight management program 2
Participants in this group receive behavioral / lifestyle support from an evidence-based commercial weight management program.
Commercial weight management program
Participants will receive evidence-based behavioral / lifestyle support from a commercial weight management program.
Commercial weight management program 3
Participants in this group receive behavioral / lifestyle support from an evidence-based commercial weight management program.
Commercial weight management program
Participants will receive evidence-based behavioral / lifestyle support from a commercial weight management program.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Commercial weight management program
Participants will receive evidence-based behavioral / lifestyle support from a commercial weight management program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ≥27 kg/m²
* Own a bodyweight scale that they can weigh themselves with during the study
* Willing and able to comply with study protocol
* Capable of providing informed consent
* Able to read and write in English
* Willing to be randomized
* Willing to sign a Non Disclosure Agreement
Exclusion Criteria
* Previous bariatric surgery or planned bariatric surgery during the study period
* Major surgery within the past 6 months or plans to have surgery during the study period
* Participation in the previous 3 months or current participation in a structured behavioral weight loss program
* Participation in another structured weight loss program during the study period (i.e., the next 3 months)
* Communication needs that would render them unable to understand the study and/or intervention materials
* Current or previous history of anorexia or bulimia nervosa
* Engagement with vomiting or laxative use within the last 28 days with the aim of controlling their shape or weight
* Currently taking anti-obesity medications, planning to take anti-obesity medications in the next 6 months, or previously taken anti-obesity medications in the previous 3 months
* Weight loss of ≥ 5 kg (11 lb) in the previous 6 months
* Self-reported diagnosis of severe depression, bipolar disorder, substance abuse, or psychosis
* Participants who are involved in any other research studies at this time
* Untreated thyroid disease or any changes (type or dose) in thyroid medication in last 6 months
* Chronic/inflammatory gastrointestinal disorders (irritable bowel syndrome is acceptable)
* History of heart problems (e.g., angina, bypass surgery, myocardial infarction, etc.) within previous 6 months
* Diagnosis of type 1 or type 2 diabetes
* Presence of implanted cardiac defibrillator or pacemaker
* History of cancer within past 5 years or current treatment for cancer
* Hospitalization for psychiatric disorders during the last 12 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
WW International Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamil Alkhaddo
Medical Director, Clinical Development
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamil Alkhaddo, MD
Role: PRINCIPAL_INVESTIGATOR
WW International Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
WW International, Inc
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
The ACE Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.